| RCKT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RCKT shares outstanding history going back to 1/5/2018:
Also see: RCKT Market Cap History RCKT YTD Return |
As of 5/1/2026 Rocket Pharmaceuticals has 109.19 million RCKT shares outstanding. Investors often track the RCKT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RCKT share count trends over time, with 34 historical shares outstanding datapoints presented, dating back to 1/5/2018.

| RCKT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RCKT shares outstanding history going back to 1/5/2018:
Also see: RCKT Market Cap History RCKT YTD Return |
| RCKT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RCKT Historical Shares Outstanding: +39.59% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RCKT Stock Price Chart |
| About Rocket Pharmaceuticals Inc |
| Rocket Pharmaceuticals, Inc. is a late-stage biotechnology company developing genetic therapies for complex and rare disorders. Its lentiviral vector-based gene therapies target hematologic diseases, including late-stage programs for Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency. The company also has in vivo adeno-associated virus programs in clinical and pre-clinical stages for Danon disease, Plakophilin-2 Arrhythmogenic Cardiomyopathy, and BAG3 Dilated Cardiomyopathy. We show 34 historical shares outstanding datapoints in our coverage of RCKT's shares outstanding history. Understanding the changing numbers of RCKT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RCKT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RCKT by allowing them to research RCKT shares outstanding history as well as any other stock in our coverage universe. |
| RCKT Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| RCKT Share Performance |
| Shares Outstanding Peers |
| Rocket Pharmaceuticals (RCKT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RCUS Shares Outstanding History RDHL Shares Outstanding History RDNT Shares Outstanding History RDY Shares Outstanding History REGN Shares Outstanding History RENB Shares Outstanding History REPH Shares Outstanding History REPL Shares Outstanding History REPR Shares Outstanding History RETA Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.